
Focused on tomorrow to
deliver better cancer care today
Oncocyte is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
Doctors and Patients
Executive Leadership
Oncocyte’s leadership team has extensive experience in molecular diagnostics and is dedicated to advancing the continuum of care.
Josh Riggs
Interim Chief Executive Officer
Gisela Paulsen
President & Chief Operating Officer
Doug Ross
MD, PhD
Chief Scientific Officer
Prof. Dr. Ekkehard Schütz
MD, PhD, FAACC
Chief Techology Officer
Anish John
Chief Financial Officer
in the power of possibilities. Do you?
We are looking for dedicated individuals to help us bring innovative solutions to physicians and patients. Interested?
Take a look at our open opportunities to become a member of Team Oncocyte!

Scientific and Medical Advisors
David R. Gandara
MD
Robert L. Ferris
MD, PhD, FACS
Daniel F. Hayes
MD, FASCO, FACP
Fred R. Hirsch
MD, PhD
John M. Kirkwood
MD
Heinz-Josef Lenz
MD, FACP
Ignacio I. Wistuba
MD
Laboratory
Oncocyte’s laboratory located in Irvine, CA, holds a CLIA Certificate of Accreditation from the Centers for Medicare and Medicaid Services (CMS). Oncocyte also holds clinical laboratory licenses from California and 48 other US states.

Events

Contact Us
References
1. National Cancer Institute. Cancer Prevalence and Cost of Care Projections. Accessed October 17, 2019 from costprojections.cancer.gov
2. American Cancer Society. Cancer Facts & Figures 2017. Atlanta: American Cancer Society; 2017.